Author: Jongwe, Tsungai Ivai
Author: Lebeko, Maribanyana R
Similar Items: Construction, stability and immunogenicity of recombinant BCG expressing HIV-1 subtype C gag under the control of MtrA promoter, with or without the leader sequences
- Evaluation of a reverse tetracycline inducible system in recombinant BCG to improve stability and immunogenicity
- Recombinant BCG expressing HIV-1 C GAG : selection of the vaccine gene and construction and evaluation as a vaccine candidate
- Recombinant Salmonella enterica serovar Typhimurium vaccine vector expressing green fluorescent protein as a model antigen or human immunodeficiency virus type 1 subtype C Gag
- The characterisation and expression of HIV-1 subtype C gag
- The development of novel HIV-1 vaccines using modified recombinant BCG
- Recombinant BCG expressing rotavirus VP6 : construction and evaluation as an anti-rotavirus vaccine
Similar Items: Evaluation of a reverse tetracycline inducible system in recombinant BCG to improve stability and immunogenicity
- Construction, stability and immunogenicity of recombinant BCG expressing HIV-1 subtype C gag under the control of MtrA promoter, with or without the leader sequences
- Recombinant BCG expressing rotavirus VP6 : construction and evaluation as an anti-rotavirus vaccine
- The development of novel HIV-1 vaccines using modified recombinant BCG
- Recombinant BCG expressing HIV-1 C GAG : selection of the vaccine gene and construction and evaluation as a vaccine candidate
- Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
- An investigation of the impact of parasitic worm infection on the immunogenicity of candidate HIV vaccines